MICHAEL DUCHSCHERE: Open Payments
NPI 1245885086 · MISSOULA, MT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$426 in 13 payments from 4 companies in 2025. Trend: 2023 $80 · 2024 $215 · 2025 $426
Food & beverage: $317Education: $109
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 5 | $227 |
| Neurocrine BioSciences, Inc. | 4 | $123 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $60 |
| Axsome Therapeutics, Inc. | 1 | $16 |
Products named: INGREZZA, AUSTEDO XR, CAPLYTA, Auvelity.
Industry payments across MT — which companies pay providers there.
